SoCalBio Conference on Tapping Non-Dilutive Funding

July 29 / 10:00 AM - 3:00 PM PDT
07/29/21 10:00 AM 07/29/21 3:00 PM America/Los_Angeles SoCalBio Conference on Tapping Non-Dilutive Funding United States

Non-dilutive funding refers to financing that does not require selling or giving away equity to raise capital. Therefore, it does not result in the dilution of the existing company owners. This meeting will focus primarily on SBIR & STTR grants for biotech, medtech, and digital health companies. The primary source of these grants is government institutions.

join us for this conference to learn how to tap SBIR/STTR funding from NIH and the DoD funding to support your firm's research. In this workshop you will learn about:
* Identifying the right agency to apply to
* How various grant programs are structured
* Submission guidelines
* Writing a successful grant proposal
* Examples for successful proposal writing
* Solicitation open and closing dates
* Grant review process
* How award decisions are made
* What is expected of your company after the research is completed
* Meeting government accounting requirements

Speakers include:
* Sheryl Flynn, PhD, CEO & Founder, Blue Marble Health
* David Hood, President & CEO, DH3 and Associates
* Natalia Kruchinin, PhD SBIR/STTR Program Coordinator, National Institute of Allergy & Infectious Diseases, NIH
* Erik Pierstroff, PhD, SBIR/STTR Program Director, National Science Foundation
* Saroj Regmi, PhD, Health Scientist Administrator, Office of Small Business Research, National Institute on Aging, NIH
* Kaushal Solanki, PhD, CEO & Founder, Eyenuk
* Robert Terbrueggen, PhD, CEO & Founder, DxTerity Diagnostics
* Patti Weber, DrPH, SBIR/STTR Program Director, National Cancer Institute, NIH

Event Cost: